申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP0710662A1
公开(公告)日:1996-05-08
A quinolinecarboxylic acid represented by general formula (C) or a medicinally acceptable salt thereof, each having a serotonergic receptor-stimulating effect on sertonin 4 receptors. In said formula, C represents hydroxymethyl, methoxy, ethoxy or morpholinyl. Therefore they have the effect of activating digestive motion and are efficacious in ameliorating chronic gastritis, diabetes and various diseases accompanying the lowering of stomach motility and gastric excretory function after gastrectomy, such as heartburn, anorexia, epigastralgia and abdominal swelling, and in treating reflux esophagitis, false ileus and constipation.
通式(C)代表的喹啉羧酸或其可药用盐,每种都对舍托宁 4 受体具有血清素能受体刺激作用。 在所述通式中,C 代表羟甲基、甲氧基、乙氧基或吗啉基。 因此,它们具有激活消化运动的作用,对改善慢性胃炎、糖尿病和胃切除术后伴随胃蠕动和胃排泄功能降低的各种疾病,如胃灼热、厌食、上腹疼痛和腹胀,以及治疗反流性食管炎、假性回肠炎和便秘具有疗效。